University of California San Francisco

Beltran Borges' picture
Beltrán Borges, MD

Research Fellow

Address

35 Medical Center Way, #903A
San Francisco, CA 94143
United States

Email: [email protected]

Biography

I was born and raised in Argentina, where I attended medical school at Universidad Nacional del Litoral. After graduation, I joined Tippi MacKenzie’s lab to work on fetal gene therapies for congenital neurological disorders, as well as the Center for Maternal Fetal Precision Medicine where I am part of the research team in a clinical trial for Prenatal Enzyme Replacement Therapy for fetuses with Lysosomal Storage Disorders. Outside of the lab, I love running, yoga and writing and hope to publish a novel one day.

Education

Institution Degree Dept or School End Date
School of Medicine, National University of Litoral MD Medicine 12/2021

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 5
  1. Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.
    Borges B, Canepa E, Chang IJ, Herzeg A, Lianoglou B, Kishnani PS, Harmatz P, MacKenzie TC, Cohen JL| | PubMed
  2. The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review.
    Herzeg A, Borges B, Diafos LN, Gupta N, MacKenzie TC, Sanders SJ| | PubMed
  3. Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus.
    Borges B, Varthaliti A, Schwab M, Clarke MT, Pivetti C, Gupta N, Cadwell CR, Guibinga G, Phillips S, Del Rio T, Ozsolak F, Imai-Leonard D, Kong L, Laird DJ, Herzeg A, Sumner CJ, MacKenzie TC| | PubMed
  4. Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.
    Clarke MT, Remesal L, Lentz L, Tan DJ, Young D, Thapa S, Namuduri SR, Borges B, Kirn G, Valencia J, Lopez ME, Lui JH, Shiow LR, Dindot S, Villeda S, Sanders SJ, MacKenzie TC| | PubMed
  5. Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects.
    Herzeg A, Borges B, Lianoglou BR, Gonzalez-Velez J, Canepa E, Munar D, Young SP, Bali D, Gelb MH, Chakraborty P, Kishnani PS, Harmatz P, Cohen JL, MacKenzie TC| | PubMed
5
View all 5 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 5
  1. Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.
    Borges B, Canepa E, Chang IJ, Herzeg A, Lianoglou B, Kishnani PS, Harmatz P, MacKenzie TC, Cohen JL| | PubMed
  2. The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review.
    Herzeg A, Borges B, Diafos LN, Gupta N, MacKenzie TC, Sanders SJ| | PubMed
  3. Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus.
    Borges B, Varthaliti A, Schwab M, Clarke MT, Pivetti C, Gupta N, Cadwell CR, Guibinga G, Phillips S, Del Rio T, Ozsolak F, Imai-Leonard D, Kong L, Laird DJ, Herzeg A, Sumner CJ, MacKenzie TC| | PubMed
  4. Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.
    Clarke MT, Remesal L, Lentz L, Tan DJ, Young D, Thapa S, Namuduri SR, Borges B, Kirn G, Valencia J, Lopez ME, Lui JH, Shiow LR, Dindot S, Villeda S, Sanders SJ, MacKenzie TC| | PubMed
  5. Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects.
    Herzeg A, Borges B, Lianoglou BR, Gonzalez-Velez J, Canepa E, Munar D, Young SP, Bali D, Gelb MH, Chakraborty P, Kishnani PS, Harmatz P, Cohen JL, MacKenzie TC| | PubMed